Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer

被引：0
|
作者：
Kenji Hashimoto
Atsuo Takashima
Kengo Nagashima
Shun-suke Okazaki
Takako Eguchi Nakajima
Ken Kato
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
机构：
[1] National Cancer Center Hospital,Gastrointestinal Oncology Division
[2] Josai University,Faculty of Pharmaceutical Sciences
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷
关键词：
Advanced gastric cancer; Second-line chemotherapy; Prognostic factor; Time to progression; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1064
页数：5
相关论文
共 50 条
  • [31] Chemotherapy beyond second-line in advanced gastric cancer
    Kim, Sung Min
    Park, Se Hoon
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (29) : 8811 - 8816
  • [32] Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients
    Vivaldi, C.
    Vasile, E.
    Fornaro, L.
    Caparello, C.
    Musettini, G.
    Pasquini, G.
    Lencioni, M.
    Ricci, S.
    Falcone, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S456 - S457
  • [33] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy containing paclitaxel for advanced gastric cancer.
    Otsuka, Ryo
    Iwasa, Satoru
    Yanai, Takako
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hashimoto, Hironobu
    Makino, Yoshinori
    Sekiguchi, Masatoshi
    Ishizone, Yoshimasa
    Boku, Narikazu
    Yamaguchi, Masakazu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [34] A randomized trial of FOLFIRI versus docetaxel and cisplatin as a second-line chemotherapy after failure of first-line chemotherapy in advanced gastric cancer
    Kil, Lee Sang
    Seok, Moon Hee
    Eun, Kim Sung
    Seok, Jang Jin
    Young, Cho Joo
    Sun, Kim Eun
    Hyung, Lee Si
    Chul, Park Jun
    Kang, Lee Yong
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [35] PREDICTIVE MARKERS FOR OVERALL AND PROGRESSION-FREE SURVIVAL WITH CAPOX IN SECOND-LINE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER
    Solis Hernandez, M. D. P.
    Jimenez Fonseca, P.
    Perez, Q.
    Alvarez Fernandez, C.
    Ruiz, L.
    Rodriguez Rubi, D.
    Li, W.
    Sanchez, M. L.
    Faez, L.
    Vieitez, J. M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 218 - 218
  • [36] Continuing bevacizumab with second-line chemotherapy for metastatic colorectal cancer prolongs overall and progression-free survival
    Williamson, Ruth
    [J]. IMMUNOTHERAPY, 2012, 4 (08) : 757 - 758
  • [37] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Ji, Sang Hoon
    Lim, Do Hyoung
    Yi, Seong Yoon
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    [J]. BMC CANCER, 2009, 9
  • [38] Is there a progression-free survival benefit of first-line crizotinib versus standard chemotherapy and second-line crizotinib in ALK-positive advanced lung adenocarcinoma? A retrospective study of Chinese patients
    Cui, Shaohua
    Zhao, Yizhuo
    Dong, Lili
    Gu, Aiqin
    Xiong, Liwen
    Qian, Jialin
    Zhang, Wei
    Niu, Yanjie
    Pan, Feng
    Jiang, Liyan
    [J]. CANCER MEDICINE, 2016, 5 (06): : 1013 - 1021
  • [39] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Sang Hoon Ji
    Do Hyoung Lim
    Seong Yoon Yi
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    [J]. BMC Cancer, 9
  • [40] Second-line chemotherapy with paclitaxel for elderly patients with advanced gastric cancer
    Ohba, Akihiro
    Takashima, Atsuo
    Nishiuchi, Takamasa
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Kato, Ken
    Hamaguchi, Tetsuya
    Nagashima, Kengo
    Boku, Narikazu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345